Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 1000 for query «pharma»

16 March, 2018 10:55 AM Bloodbath on Dalal Street; Sensex tumbles over 500 points, Nifty drops below 10,200

New Delhi: A huge sell-off across all sectors – led by oil and gas, metals, auto and banking stocks –dragged the Indian equity to close deep into the red on Friday. The BSE Sensex shed over 509.54 points or 1.51 percent to close at 33,128.99 while the NSE Nifty dropped 165.00 points or 1.59 percent to close at 10,195.15. The BSE market breadth was bearish 37

1 March, 2018 5:06 PM Pharma pricing panel chief Bhupendra Singh shunted out

Bhupendra Singh had pointed out profiteering by private hospitals Ten days after he released evidence of profiteering by private hospitals when dengue broke out, National Pharmaceutical Pricing Authority (NPPA) chairman Bhupendra Singh was transferred on Wednesday night. The NPAA investigation found that four private hospitals were forcing patients to buy drugs 36

1 March, 2018 12:33 PM Torrent shareholders clear hike in borrowing limit to Rs 15k crore

Torrent Pharmaceuticals on Thursday said it has received shareholders' nod to enhance borrowing limit from Rs 10,000 crore to Rs 15,000 crore. Torrent Pharmaceuticals on Thursday said it has received shareholders' nod to enhance borrowing limit from Rs 10,000 crore to Rs 15,000 crore. The shareholders have given approval through postal ballot, Torrent 41

28 February, 2018 4:54 AM Market Update: ICICI Bank falls over 2%, drags Bank Nifty lower; Ashok Leyland hits new 52-week high

The top Nifty gainers included Cipla which was up 1.2 percent, Dr Reddy's Labs gained 1 percent followed by Sun Pharma, UPL and Infosys while the most active stock was PNB which was down 4.4 percent, followed by Biocon which gained 3 percent. The Indian benchmark indices were trading on a negative note on Wednesday morning with the Nifty shedding 69 points 100

26 February, 2018 5:22 AM Remain neutral on Sun Pharma; many other issues like Taro results persist: Analyst

Sun Pharma has received 3 observations from US FDA in a re-inspection. In an interview with CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his views and readings on the same. We don’t know yet, how serious these observations are and these are just classifications, sometimes in each of these observations, there could be several instances 29

19 February, 2018 2:32 AM Stocks in the news: Tata Steel, PNB, Gitanjali, Natco Pharma, KPR Mills, Bhushan Steel, PVR

Tata Steel | PNB | Infosys | Gitanjali Gems | KPR Mills | Religare Enterprises | Bhushan Steel | Natco Pharma | PVR | ARSS Infra | IOC | NTPC | Power Grid | Fortis Healthcare and Binani Cement are stocks, which are in the news today. -Binani Industries moves NCLT, seeks to become party to sale of arm Binani Cement under Insolvency and Bankruptcy Code (IBC) 52

16 February, 2018 8:30 AM SC rejects Ranbaxy promoters' petition to challenge HC ruling in favour of Daiichi Sankyo

Ranbaxy Laboratories Ltd had allegedly concealed information about proceedings against them by American food and drug department. New Delhi: Supreme Court on Friday rejected the petition of Ranbaxy promoters Malvinder and Shivinder Singh seeking permission to appeal a High Court judgement allowing Daiichi Sankyo to recover about Rs 3,500 crores from them as part of an international 45

14 February, 2018 12:10 PM Sun Pharma Q3 Profit Slides 75% To Rs 365 Crore, Misses Estimates

India's largest drugmaker Sun Pharmaceutical Industries Ltd reported on Wednesday a 75 per cent drop in net profit in the quarter ending Dec. 31, well below analysts' estimates. Net profit fell to 3.65 billion rupees ($57 million) in the firm's third quarter from 14.72 billion rupees a year earlier, the company said. That compared with the 9.12 billion 44

9 February, 2018 7:10 AM Jubilant Pharma gets USFDA nod for Symmetrel's generic version

Drug firm Jubilant Life Sciences today said its subsidiary has received final approval from the US health regulator for Amantadine Hydrochloride tablets, an anti-viral and anti-Parkinsons drug. The approved drug, generic version of Symmetrel of Endo, is indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains 44

9 February, 2018 5:16 AM Market may correct more if sentiment weakens ahead of general elections: IndAsia Fund Advisors

The correction that we have seen so far can be largely attributed to the global factors although the imposition of the long-term capital gains (LTCG) can also be blamed for massive outflows seen in the equity markets. But, a major shift could happen if there is a sentiment change with respect to the outcome of the upcoming general elections which could 36